Access to medicines: lessons from the HIV response

Lancet HIV. 2017 Apr;4(4):e147-e149. doi: 10.1016/S2352-3018(17)30052-8.
No abstract available

MeSH terms

  • Anti-HIV Agents / economics*
  • Anti-HIV Agents / therapeutic use
  • Developed Countries
  • Developing Countries
  • Drugs, Essential / economics
  • Drugs, Essential / therapeutic use
  • HIV Infections / drug therapy*
  • HIV Infections / economics
  • Health Services Accessibility / ethics
  • Humans

Substances

  • Anti-HIV Agents
  • Drugs, Essential